Want to see GH full AI Analyst Report?
Guardant Health (GH) Ratios
Guardant Health Ratios
GH's free cash flow for Q2 2026 was $-69.54M. For the 2026 fiscal year, GH's free cash flow was decreased by $-11.76M and operating cash flow was $-57.78M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.84 | 4.68 | 6.54 | 6.17 | 5.72 |
| Quick Ratio | 4.56 | 4.36 | 6.24 | 5.90 | 5.57 |
| Cash Ratio | 1.25 | 2.33 | 5.50 | 0.73 | 2.53 |
| Solvency Ratio | -0.18 | -0.24 | -0.27 | -0.40 | -0.25 |
| Operating Cash Flow Ratio | -0.61 | -1.06 | -1.58 | -1.60 | -1.07 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -8.21 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -646.92M | $ -570.14M | $ -280.63M | $ -358.21M | $ -445.37M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.85 | 0.90 | 0.76 | 0.85 | 0.62 |
| Debt-to-Equity Ratio | -17.22 | -9.57 | 8.53 | 22.75 | 2.13 |
| Debt-to-Capital Ratio | 1.06 | 1.12 | 0.90 | 0.96 | 0.68 |
| Long-Term Debt-to-Capital Ratio | 1.07 | 1.14 | 0.88 | 0.95 | 0.64 |
| Financial Leverage Ratio | -20.28 | -10.64 | 11.26 | 26.75 | 3.42 |
| Debt Service Coverage Ratio | -95.62 | -12.31 | -168.34 | -239.06 | -139.67 |
| Interest Coverage Ratio | -112.20 | -171.87 | -219.06 | -211.24 | -159.49 |
| Debt to Market Cap | 0.12 | 0.31 | 0.38 | 0.41 | 0.11 |
| Interest Debt Per Share | 13.67 | 10.91 | 12.11 | 13.43 | 13.58 |
| Net Debt to EBITDA | -3.56 | -2.08 | -0.51 | -2.00 | -2.45 |
| Profitability Margins | |||||
| Gross Profit Margin | 64.46% | 60.79% | 59.74% | 65.23% | 67.11% |
| EBIT Margin | -42.12% | -58.52% | -84.44% | -144.79% | -102.21% |
| EBITDA Margin | -38.08% | -52.79% | -76.83% | -136.79% | -96.24% |
| Operating Profit Margin | -44.53% | -60.02% | -100.14% | -121.10% | -110.00% |
| Pretax Profit Margin | -42.52% | -58.87% | -84.90% | -145.36% | -102.89% |
| Net Profit Margin | -42.39% | -59.05% | -85.02% | -145.61% | -108.57% |
| Continuous Operations Profit Margin | -42.39% | -59.05% | -85.02% | -145.61% | -102.98% |
| Net Income Per EBT | 99.70% | 100.30% | 100.14% | 100.17% | 105.51% |
| EBT Per EBIT | 95.49% | 98.08% | 84.78% | 120.04% | 93.54% |
| Return on Assets (ROA) | -20.67% | -29.37% | -26.84% | -40.66% | -18.40% |
| Return on Equity (ROE) | 419.18% | 312.48% | -302.14% | -1087.72% | -62.89% |
| Return on Capital Employed (ROCE) | -25.56% | -35.21% | -35.73% | -38.42% | -20.45% |
| Return on Invested Capital (ROIC) | -25.07% | -34.41% | -35.11% | -37.84% | -20.32% |
| Return on Tangible Assets | -21.79% | -29.57% | -27.02% | -41.04% | -18.55% |
| Earnings Yield | -3.25% | -11.64% | -15.83% | -23.55% | -4.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.12 | 6.70 | 6.35 | 4.62 | 3.83 |
| Payables Turnover | 6.41 | 7.52 | 4.39 | 2.27 | 3.19 |
| Inventory Turnover | 4.06 | 4.08 | 3.67 | 3.03 | 4.01 |
| Fixed Asset Turnover | 3.22 | 2.65 | 1.86 | 1.31 | 1.19 |
| Asset Turnover | 0.49 | 0.50 | 0.32 | 0.28 | 0.17 |
| Working Capital Turnover Ratio | 0.99 | 0.75 | 0.53 | 0.47 | 0.27 |
| Cash Conversion Cycle | 84.11 | 95.43 | 73.87 | 38.54 | 72.10 |
| Days of Sales Outstanding | 51.24 | 54.45 | 57.46 | 78.97 | 95.39 |
| Days of Inventory Outstanding | 89.81 | 89.53 | 99.59 | 120.48 | 91.09 |
| Days of Payables Outstanding | 56.94 | 48.55 | 83.18 | 160.90 | 114.38 |
| Operating Cycle | 141.05 | 143.98 | 157.05 | 199.44 | 186.48 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.47 | -1.95 | -2.90 | -3.03 | -2.06 |
| Free Cash Flow Per Share | -1.86 | -2.24 | -3.08 | -3.79 | -2.80 |
| Dividend Paid and CapEx Coverage Ratio | -3.82 | -6.84 | -15.86 | -4.00 | -2.79 |
| Capital Expenditure Coverage Ratio | -3.82 | -6.84 | -15.86 | -4.00 | -2.79 |
| Operating Cash Flow Coverage Ratio | -0.11 | -0.18 | -0.24 | -0.23 | -0.15 |
| Operating Cash Flow to Sales Ratio | -0.19 | -0.32 | -0.58 | -0.69 | -0.56 |
| Free Cash Flow Yield | -1.82% | -7.33% | -11.40% | -13.92% | -2.80% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -30.77 | -8.58 | -6.32 | -4.25 | -24.98 |
| Price-to-Sales (P/S) Ratio | 13.04 | 5.07 | 5.37 | 6.18 | 27.12 |
| Price-to-Book (P/B) Ratio | -128.95 | -26.85 | 19.09 | 46.18 | 15.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -54.94 | -13.64 | -8.77 | -7.18 | -35.67 |
| Price-to-Operating Cash Flow Ratio | -69.31 | -15.63 | -9.32 | -8.98 | -48.48 |
| Price-to-Earnings Growth (PEG) Ratio | 4.56 | 0.51 | 0.19 | -0.06 | -0.50 |
| Enterprise Value Multiple | -37.81 | -11.69 | -7.50 | -6.52 | -30.63 |
| Enterprise Value | 14.14B | 4.56B | 3.25B | 4.01B | 11.01B |
| EV to EBITDA | -37.81 | -11.69 | -7.50 | -6.52 | -30.63 |
| EV to Sales | 14.40 | 6.17 | 5.76 | 8.91 | 29.48 |
| EV to Free Cash Flow | -60.66 | -16.59 | -9.41 | -10.36 | -38.78 |
| EV to Operating Cash Flow | -76.52 | -19.01 | -10.00 | -12.95 | -52.70 |
| Tangible Book Value Per Share | -1.62 | -1.22 | 1.31 | 0.44 | 6.19 |
| Shareholders’ Equity Per Share | -0.79 | -1.14 | 1.42 | 0.59 | 6.37 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 7.83 | 6.02 | 5.04 | 4.40 | 3.69 |
| Net Income Per Share | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.06 |
| Interest Burden | 1.01 | 1.01 | 1.01 | 1.00 | 1.01 |
| Research & Development to Revenue | 0.37 | 0.47 | 0.65 | 0.83 | 0.70 |
| SG&A to Revenue | 0.72 | 0.74 | 0.28 | 0.36 | 0.55 |
| Stock-Based Compensation to Revenue | 0.17 | 0.19 | 0.16 | 0.21 | 0.41 |
| Income Quality | 0.44 | 0.55 | 0.68 | 0.47 | 0.54 |
Currency in USD
